window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 27, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

regenerative medicine

  • Cell & Gene Therapy,Clinical Development,Partnerships & Funding,Rare Diseases

    Kidswell Bio and Treehill Partners launch US newco to advance cell therapy for paediatric cerebral palsy

    Kidswell Bio and Treehill Partners have launched a US-based regenerative [...]

    February 16, 2026
  • Biomanufacturing,CDMOs & Manufacturing,Cell & Gene Therapy,Pharmaceuticals and therapeutics

    NurExone joins ARMI BioFab Startup Lab to boost US regenerative manufacturing

    NurExone Biologic Inc has been accepted into the BioFab Startup [...]

    November 5, 2025
  • Biologics & Biosimilars,CDMOs & Manufacturing,Cell & Gene Therapy,Pharmaceuticals and therapeutics,Technology and platforms

    RION partners with Lonza to scale manufacturing of exosome-based therapeutics

    RION, a commercial and clinical-stage regenerative medicine company pioneering platelet-derived [...]

    September 23, 2025
  • Medical devices,Movers & Shakers,Pharmaceuticals and therapeutics,Technology and platforms

    Oral BioLife appoints Greg Ambra as CEO and strengthens leadership team

    Oral BioLife, a regenerative technology company developing non-invasive therapies to [...]

    September 23, 2025
  • Drug Development,Partnerships & Funding,Rare Diseases,Research & Development

    DEBRA Research and Queen Mary University of London partner to advance drug development for rare skin disorder

    DEBRA Research, a non-profit focused on Epidermolysis bullosa (EB), has [...]

    August 7, 2025
  • Biologics & Biosimilars,CDMOs & Manufacturing,Cell & Gene Therapy,Research & Development

    PL BioScience opens new headquarters to support growing demand for HPL production

    1,200 m² Aachen facility will enable largest global HPL output [...]

    August 1, 2025
  • Market Access & Commercialization,Medical devices,Regulatory Affairs,Technology and platforms

    TISSIUM secures FDA De Novo nod for sutureless nerve repair system

    TISSIUM has received De Novo authorization from the US Food [...]

    July 17, 2025
  • Cell & Gene Therapy,Clinical Trials,Rare Diseases

    Rare bone disorder: Novadip reports long-term success for pediatric patients treated under compassionate use programme

    Novadip Biosciences and Cliniques universitaires Saint-Luc have reported successful long-term [...]

    July 17, 2025
  • Cell & Gene Therapy,Clinical Development,Regulatory Affairs

    Nanoscope Therapeutics begins FDA submission for gene-agnostic therapy to treat retinitis pigmentosa

    Nanoscope Therapeutics has initiated a rolling submission for its Biologics [...]

    July 15, 2025
  • Biologics & Biosimilars,CDMOs & Manufacturing,Cell & Gene Therapy

    Celularity and Fountain Life partner to deliver stem cell therapies under new Florida Law

    Celularity and Fountain Life have formed a strategic partnership to [...]

    July 15, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Neomorph raises $100 million to advance NEO-811 Phase 1/2 cancer trial and molecular glue degrader pipeline
    Categories: Biotech, Clinical Trials, Drug discovery, Funding, Oncology, Partnerships & Funding, Pharmaceuticals and therapeutics, Research & Development, Technology and platforms
  • NICE expands Lokelma access for hyperkalaemia after draft recommendation
    Categories: Cardiovascular diseases, Chronic diseases, Market Access & Commercialization, Pharmaceuticals and therapeutics, Regulatory Affairs
  • Oncodesign expands ARRONAX deal to secure astatine-211 supply for radiotherapy research
    Categories: CDMOs & Manufacturing, Drug Development, European biotech, Logistics and distribution, Oncology, Partnerships & Funding, Supply Chain & Logistics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top